#kidney disease

Studies highlight the need for better prevention and management of age-related health problems.

Maintaining an undetectable viral load can halt progression of HIV and eliminate the risk of transmission.

Five years of follow-up data show that starting antiretroviral therapy with a higher CD4 count has long-lasting benefits.

Research on links between tenofovir, SARS-CoV-2 infection and COVID severity have yielded mixed results, but new study suggests it helps.

While vaccination typically provides robust protection against severe disease, they’re less effective for immunocompromised people.

A large study found that heart disease and mental health conditions are driving use of multiple medications as people age.

A growing number of transplant programs are barring patients who refuse COVID vaccines or giving them lower priority on waiting lists.

In the context of universal health care, this may be a result of more frequent access to care.

As people with HIV live longer thanks to effective antiretroviral treatment, they are prone to a host of additional health problems.

Congress passed a law in 2013 allowing such organ transplants in research studies.

Among people with well-treated HIV, age-associated non-AIDS-related health conditions are increasing.

Researchers compared data on more than 9,000 people with HIV who took either version of tenofovir.

That’s according to a study of 55 HIV-positive people with end-stage kidney failure.